Lantheus Holdings, Inc.

LNTH Healthcare Drug Manufacturers Specialty & Generic

Lantheus Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 0.50% from fiscal 2024.

Revenue
+1.54%
EPS
−17.1%
Free cash flow
+7.71%
Total debt
+0.52%

Quarter to September 2026, against a year earlier

100.76 0.38 −0.38%
Market cap
$6.6B
P/E
24.3×
Fwd P/E
21.3×
Dividend yield
—
F-score
5/9
Altman Z
4.25
Beneish M
−2.23
Dividend safety
n/a

Lantheus Holdings, Inc. (LNTH) Book value per share

Alert me on Book value per share

Lantheus Holdings, Inc.'s book value per share at the end of fiscal 2025 was 16.1×, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was 20.8×. Over the past ten years it has ranged from −7.6× (fiscal 2015) to 16.1× (fiscal 2025) — the current reading is the highest in ten years. Lantheus Holdings, Inc. ranks 7th of 84 Drug Manufacturers Specialty & Generic companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 16.1× 2.70%
FY2024 15.7× 31.55%
FY2023 12.0× 83.06%
FY2022 6.5× (5.13%)
FY2021 6.9× (27.55%)
FY2020 9.5× 223.15%
FY2019 2.9× 58.28%
FY2018 1.9× 197.23%
FY2017 0.6× —
FY2016 −3.3× —

Quarterly newest first

Period Book value per share Change
Sep 2026 20.8× 3.13%
Jun 2026 20.1× 7.50%
Mar 2026 18.7× 15.97%
Dec 2025 16.1× (3.00%)
43 more quarters

Against its own ten years

Low −7.6× High 16.1×
Ten-year median 6.5×
Current reading's percentile 100

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on LNTH